Search hospitals > Nebraska > Kearney
CHI Health Good Samaritan
Claim this profileKearney, Nebraska 68847
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
241 reported clinical trials
3 medical researchers
Summary
CHI Health Good Samaritan is a medical facility located in Kearney, Nebraska. This center is recognized for care of Thyroid Cancer, Breast Cancer, Stomach Cancer, Lung Cancer, Breast cancer and other specialties. CHI Health Good Samaritan is involved with conducting 241 clinical trials across 397 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Thyroid Cancer
Expert in Breast Cancer
178 reported clinical trials
242 drugs studied
Shahzad SiddiquePenrose-Saint Francis Healthcare2 years of reported clinical research
Expert in Thyroid Cancer
Expert in Breast Cancer
124 reported clinical trials
186 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Clinical Trials running at CHI Health Good Samaritan
Breast Cancer
Lung Cancer
Bladder Cancer
Thyroid Cancer
Breast cancer
Stomach Cancer
Multiple Myeloma
Prostate Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at CHI Health Good Samaritan?
CHI Health Good Samaritan is a medical facility located in Kearney, Nebraska. This center is recognized for care of Thyroid Cancer, Breast Cancer, Stomach Cancer, Lung Cancer, Breast cancer and other specialties. CHI Health Good Samaritan is involved with conducting 241 clinical trials across 397 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.